Access practice tools, as well as industry leading news, customizable alerts, dockets, and primary content, including a comprehensive collection of case law, dockets, and regulations. Leverage...
By Tony Dutra
Nov. 17 — Patent valuations have gone as low as they possible can, making bargains available, and foreign patents can boost the value of portfolios, members of the intellectual property investment community said.
“There’s a lot of unspent money set aside for transactions that hasn’t been spent yet,” Peter Toto, Sony Corp of America’s vice president for IP said. “We’re waiting for signs.”
There are a number of reasons for tentative optimism in the market for intellectual property investors and IP portfolio managers, from U.S. court decisions to the election of Donald Trump, said participants at the IP Dealmakers forum held Nov. 17 in New York.
Oddly, one of the most promising “signs” might be patent owner wins in China, after years of perception that the country has little respect for IP rights.
“Since we’re starting from rock bottom, it can only go up,” said Louis Carbonneau, CEO of IP monetization firm Tangible IP.
Presenters and audience members cited prospects for change in U.S. patent law, such as Federal Circuit rulings that software inventions are patent-eligible and a prediction that the regulatory environment under President-elect Donald Trump will be friendlier to small and medium sized innovative companies.
But what makes a good patent portfolio didn’t depend on changes to U.S. law, speakers said. Instead, it’s the inclusion of foreign patents parallel to the U.S. versions.
The problem for companies licensing patents is the inability to get an injunction in the U.S. since the Supreme Court’s decision in 2006 in eBay Inc. v. MercExchange LLC. Without the leverage that a U.S. infringer will be barred from a market, prospective licensees ignore licensing offers.
However, countries such as Germany and China are highly likely to grant an injunction. The ability to get an injunction may make investing in China’s developing IP market a key strategy for patent investment companies.
Erick Robinson, chief patent counsel for Asia Pacific for Rouse China said that Chinese courts have granted injunctions to winning U.S. companies against Chinese defendants in 100 percent of the recent cases. Damages are small, he said, but it’s basically a “guaranteed injunction” if you win, and the win rate is running 75 to 95 percent.
There are no examples yet, but if the success rates continue, significant leverage, usable back in the U.S., would accrue to the U.S. owner of a Chinese patent asserted in China against a U.S. defendant. And the best hypothetical example is Apple inc., Robinson said, because 100 percent of the iPhone is made in China.
Also important to the patent investment community is that Chinese courts have no bias against non-practicing entities, he said. NPEs make a profit from acquiring patents and licensing them, but don’t make a product themselves.
An NPE win against Apple in China and a subsequent manufacturing injunction would provide leverage for the NPE in the U.S. under this scenario.
“Imagine Apple enjoined from shipping goods from China,” Charbonneau said.
Russell Binns, CEO of Allied Security Trust, a member-based patent holding company, distinguished the current way his firm evaluates patent portfolios from just a couple of years ago.
Foreign patents are “no longer a throw-in,” he said. “We still want to see the U.S. assets. But foreign assets are driving up the value a little more.”
To contact the reporter on this story: Tony Dutra in Washington at firstname.lastname@example.org
To contact the editor responsible for this story: Mike Wilczek at email@example.com
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to firstname.lastname@example.org.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to email@example.com.
Put me on standing order
Notify me when new releases are available (no standing order will be created)